您的位置:中国博士人才网 > 博士后招收 > 海外博士后招收 > 美国加州大学洛杉矶分校博士后研究员职位-纳米疗法,癌症和免疫疗法方向

关注微信

美国加州大学洛杉矶分校博士后研究员职位-纳米疗法,癌症和免疫疗法方向

时间:2021-01-11来源:中国博士人才网 作者:佚名

Postdoctoral Researcher - Nanotherapeutics, Cancer and Immunotherapy

The UCLA Division of NanoMedicine and California NanoSystems Institute (CNSI) at the University of California, Los Angeles are recruiting a postdoctoral researcher to join a team of highly integrated scientists exploring the use of engineered nanomaterials for cancer chemotherapy and chemo-immunotherapy applications.  We are looking for an individual with hands-on experience in the use of nanomaterials for drug delivery and tumor immunology applications.

We are looking for a highly qualified Postdoctoral Researcher with superior knowledge of nanotherapeutics, tumor immunology, drug delivery and nanomaterial-enabled immunotherapy to perform research utilizing nanocarriers and nanocarrier design to develop a chemo-immunotherapy platform in CNSI. The successful candidate will possess interdisciplinary skills and hands-on experience in conducting nanomaterial synthesis and cellular and animal studies based on a detailed understanding of nanomaterial properties and cargos to deliver drugs and raise anti-tumor responses. Postdoctoral researcher will assist in planning of experiments, methods development, and conduct productive research in the field of tumor chemo-immunotherapy.

Position is available for immediate occupancy for minimally a 1-2 year appointment, contingent on background experience, performance, and continued availability of funding.  Candidate must have completed a PhD in immunology, cancer biology or materials science and have hands-on experience in nanotherapeutics. Candidates with pharmaceutical science expertise and drug delivery experience are encouraged to apply.  Applicants who have already served 3 years as a Postdoctoral Researcher at other institutions are not eligible to apply.

为防止简历投递丢失请抄送一份至:boshijob@126.com(邮件标题格式:应聘职位名称+姓名+学历+专业+中国博士人才网)

中国-博士人才网发布

声明提示:凡本网注明“来源:XXX”的文/图等稿件,本网转载出于传递更多信息及方便产业探讨之目的,并不意味着本站赞同其观点或证实其内容的真实性,文章内容仅供参考。